75 related articles for article (PubMed ID: 9128141)
1. Targeted delivery of human neurofibromin and c-Raf-1 mutants to the cytoplasmic membrane by use of the influenza virus hemagglutinin.
Nur-E-Kamal MS; Reverey H; Ponimaskin E; Schroth-Diez B; Herrmann A; Schmidt MF
Biochim Biophys Acta; 1997 Apr; 1338(2):233-43. PubMed ID: 9128141
[TBL] [Abstract][Full Text] [Related]
2. Fusion activity of transmembrane and cytoplasmic domain chimeras of the influenza virus glycoprotein hemagglutinin.
Schroth-Diez B; Ponimaskin E; Reverey H; Schmidt MF; Herrmann A
J Virol; 1998 Jan; 72(1):133-41. PubMed ID: 9420208
[TBL] [Abstract][Full Text] [Related]
3. Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion.
Li M; Li ZN; Yao Q; Yang C; Steinhauer DA; Compans RW
J Virol; 2006 Jun; 80(12):6106-14. PubMed ID: 16731949
[TBL] [Abstract][Full Text] [Related]
4. Polarized expression of a chimeric protein in which the transmembrane and cytoplasmic domains of the influenza virus hemagglutinin have been replaced by those of the vesicular stomatitis virus G protein.
McQueen N; Nayak DP; Stephens EB; Compans RW
Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9318-22. PubMed ID: 3025835
[TBL] [Abstract][Full Text] [Related]
5. Heterologous transmembrane and cytoplasmic domains direct functional chimeric influenza virus hemagglutinins into the endocytic pathway.
Roth MG; Doyle C; Sambrook J; Gething MJ
J Cell Biol; 1986 Apr; 102(4):1271-83. PubMed ID: 3007532
[TBL] [Abstract][Full Text] [Related]
6. Modification of the cytoplasmic domain of influenza virus hemagglutinin affects enlargement of the fusion pore.
Kozerski C; Ponimaskin E; Schroth-Diez B; Schmidt MF; Herrmann A
J Virol; 2000 Aug; 74(16):7529-37. PubMed ID: 10906206
[TBL] [Abstract][Full Text] [Related]
7. Endocytosis of chimeric influenza virus hemagglutinin proteins that lack a cytoplasmic recognition feature for coated pits.
Lazarovits J; Naim HY; Rodriguez AC; Wang RH; Fire E; Bird C; Henis YI; Roth MG
J Cell Biol; 1996 Jul; 134(2):339-48. PubMed ID: 8707820
[TBL] [Abstract][Full Text] [Related]
8. The role of the cytoplasmic tail region of influenza virus hemagglutinin in formation and growth of fusion pores.
Melikyan GB; Jin H; Lamb RA; Cohen FS
Virology; 1997 Aug; 235(1):118-28. PubMed ID: 9300043
[TBL] [Abstract][Full Text] [Related]
9. Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion.
Takeda M; Leser GP; Russell CJ; Lamb RA
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14610-7. PubMed ID: 14561897
[TBL] [Abstract][Full Text] [Related]
10. Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin.
Panicali D; Davis SW; Weinberg RL; Paoletti E
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5364-8. PubMed ID: 6310573
[TBL] [Abstract][Full Text] [Related]
11. Assessment of fusogenic properties of influenza virus hemagglutinin deacylated by site-directed mutagenesis and hydroxylamine treatment.
Philipp HC; Schroth B; Veit M; Krumbiegel M; Herrmann A; Schmidt MF
Virology; 1995 Jun; 210(1):20-8. PubMed ID: 7793071
[TBL] [Abstract][Full Text] [Related]
12. Identification of viral membrane proteins required for cell fusion and viral dissemination that are modified during vaccinia virus persistence.
Ortiz MA; Paez E
Virology; 1994 Jan; 198(1):155-68. PubMed ID: 8259650
[TBL] [Abstract][Full Text] [Related]
13. Analysis of progressive deletions of the transmembrane and cytoplasmic domains of influenza hemagglutinin.
Doyle C; Sambrook J; Gething MJ
J Cell Biol; 1986 Oct; 103(4):1193-204. PubMed ID: 3771631
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic tail length influences fatty acid selection for acylation of viral glycoproteins.
Veit M; Reverey H; Schmidt MF
Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):163-72. PubMed ID: 8761467
[TBL] [Abstract][Full Text] [Related]
15. Peptides containing a consensus Ras binding sequence from Raf-1 and theGTPase activating protein NF1 inhibit Ras function.
Clark GJ; Drugan JK; Terrell RS; Bradham C; Der CJ; Bell RM; Campbell S
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1577-81. PubMed ID: 8643674
[TBL] [Abstract][Full Text] [Related]
16. Biosynthesis and intracellular sorting of growth hormone-viral envelope glycoprotein hybrids.
Rizzolo LJ; Finidori J; Gonzalez A; Arpin M; Ivanov IE; Adesnik M; Sabatini DD
J Cell Biol; 1985 Oct; 101(4):1351-62. PubMed ID: 2995406
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid.
Staschke KA; Hatch SD; Tang JC; Hornback WJ; Munroe JE; Colacino JM; Muesing MA
Virology; 1998 Sep; 248(2):264-74. PubMed ID: 9721235
[TBL] [Abstract][Full Text] [Related]
18. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins.
Latham T; Galarza JM
J Virol; 2001 Jul; 75(13):6154-65. PubMed ID: 11390617
[TBL] [Abstract][Full Text] [Related]
19. On the role of the transmembrane anchor sequence of influenza hemagglutinin in target cell recognition by class I MHC-restricted, hemagglutinin-specific cytolytic T lymphocytes.
Braciale TJ; Braciale VL; Winkler M; Stroynowski I; Hood L; Sambrook J; Gething MJ
J Exp Med; 1987 Sep; 166(3):678-92. PubMed ID: 2442285
[TBL] [Abstract][Full Text] [Related]
20. Influenza virus hemagglutinin containing an altered hydrophobic carboxy terminus accumulates intracellularly.
Sveda MM; Markoff LJ; Lai CJ
J Virol; 1984 Jan; 49(1):223-8. PubMed ID: 6690711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
